Advicenne
is a biopharmaceutical company that develops and commercializes tubular acidosis therapeutics for the treatment of kidney diseases... Read moreAdvicenne
is a biopharmaceutical company that develops and commercializes tubular acidosis therapeutics for the treatment of kidney diseases... Read more
News
Mar 27, 2025
FinanzNachrichten
Advicenne: Advicenne: Fiscal Year 2024 Marked by the Satisfactory Commercial Performance of Sibnayal in Europe and Development in the United States
Jan 29, 2025
FinanzNachrichten
Advicenne: Advicenne Reaches a Significant Milestone With the US FDA in the Development of ADV7103 in Cystinuria
Jan 23, 2025
FinanzNachrichten
Advicenne: Advicenne Announces 2024 Gross Sales1
Dec 19, 2024
FinanzNachrichten
Advicenne: Advicenne Finalizes Agreement with Primex Pharmaceuticals AG
Oct 01, 2024
FinanzNachrichten
Advicenne: Advicenne achieves major milestones in the US thanks to several positive FDA opinions on ADV7103
Sep 19, 2024
FinanzNachrichten
Advicenne: Advicenne Reports Its First Half Financial Results as of June 30, 2024, and Updates on Its Activities
Sep 18, 2024
Business Wire
Press Release: Advicenne : Advicenne prsente ses rsultats financiers semestriels au 30 juin 2024 et fait le point sur ses activits
Jul 19, 2024
MarketScreener
Advicenne: Advicenne: Primex unable to meet its commitments
Jul 18, 2024
Marketscreener
Advicenne: Advicenne Announces an 8.8% Increase in Gross Sales for H1 2024 and Provides an Update on Its Activities
May 15, 2024
MarketScreener
Advicenne: Advicenne Announces the Approval of All Resolutions Supported by the Board of Directors at Its Combined General Meeting
Advicenne Competitors
1
2
3
4
5
6
7
8
9
10